Prostate specific antigen (PSA)

Reference

Reference
Glenski WJ, Klee GG, Bergstralh EJ, Oesterling JE. , 1992, Prostate, 21(2), 99-110 , Prostate-specific antigen: establishment of the reference range for the clinically normal prostate gland and the effect of digital rectal examination, ejaculation, and time on serum concentrations

Scoring

Total Score

C6,7,8,10,11,12,13

Parameter Score
1. Scale A
2. Study Population A
3. Samples A
4. Measurand B
5. Pre-Analytical A
6. Replicate Analysis C
7. Steady State C
8. Outlier Analysis C
9. Normality B
10. Variance Homogeneity C
11. ANOVA C
12. CI C
13. No of Results C
14. Concentrations A
15. Total Score C6,7,8,10,11,12,13
Comment

Item Details

Parameter Score
Matrix Serum
Measurand Prostate specific antigen (PSA)
Unit ng / mL
Overall Analytical Principle Method Immunoassay; Other
Number of Subjects 20
Number of Subjects included in BV estimation 20
Ethinicity Unknown
Age Mean / Median
Age Min
Age Max
Age SD
Number of Males 20
Number of Females 0
State of Well Being
Healthy (excl pregnant)
Diseases
Study Duration Length 1
Study Duration Units Month
Sampling Intervals, e.g. X sample(s) per Interval Unit
Interval Units Other
Sampling Times Start Time: 07:00
End Time: 16:00
Number of Samples 40
Average Number of Samples Used for BV Estimation 40.0
Average Number of Replicates 1.0
Estimates of CVi 16.5
Calculated Confidence Intervals of CVi Lower: 15.63, Upper: 17.43
Estimates of CVg
Calculated Confidence Intervals of CVg Lower: , Upper:
Analytical CV 4.6
Calculated Confidence Intervals of Analytical CV Lower: 3.98, Upper: 5.44
Measurand Mean
Measurand Min
Measurand Max
Measurand SD

Coding